CIM
BHC icon

Contravisory Investment Management’s Bausch Health BHC Stock Holding History

Contravisory Investment Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,046
Closed -$127K – 280
2019
Q2 		$127K Hold
5,046
– – 0.05% 161
2019
Q1 		$125K Sell
5,046
-592
-11% -$14.1K 0.05% 166
2018
Q4 		$104K Buy
+5,638
New +$134K 0.04% 173

Other funds holding BHC

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Contravisory Investment Management's BHC Position: Q3 2019 in Review

Contravisory Investment Management sold out of Bausch Health (BHC) in Q3 2019, closing a stake of 5,046 shares — an estimated $127K sold.

Contravisory Investment Management first reported a position in BHC in Q4 2018 and held it in 3 quarters. The position peaked at $127K in Q2 2019. 315 funds tracked by Wall St. Rank hold BHC as of Q3 2019.

  • Contravisory Investment Management reported no remaining Bausch Health position as of Q3 2019 after selling out during the quarter.
  • Contravisory Investment Management sold 5,046 Bausch Health shares in Q3 2019, an estimated $127K.
  • Contravisory Investment Management first reported a position in Bausch Health in Q4 2018 and held it in 3 quarters.
  • Contravisory Investment Management's Bausch Health position peaked at $127K in Q2 2019.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q3 2019.

Based on Contravisory Investment Management's 13F filing for Q3 2019, filed 7 Oct 2019.